177 related articles for article (PubMed ID: 15501813)
1. In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists.
Rajagopalan G; Sen MM; David CS
Infect Immun; 2004 Nov; 72(11):6733-7. PubMed ID: 15501813
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.
Rajagopalan G; Smart MK; Cheng S; Krco CJ; Johnson KL; David CS
Tissue Antigens; 2003 Aug; 62(2):149-61. PubMed ID: 12889995
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
4. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal enterotoxin B-induced activation and concomitant resistance to cell death in CD28-deficient HLA-DQ8 transgenic mice.
Rajagopalan G; Smart MK; Marietta EV; David CS
Int Immunol; 2002 Jul; 14(7):801-12. PubMed ID: 12096040
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain.
Rajagopalan G; Smart MK; Krco CJ; David CS
J Immunol; 2002 Aug; 169(4):1774-83. PubMed ID: 12165499
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
[TBL] [Abstract][Full Text] [Related]
8. Concomitant Disruption of
Chowdhary VR; Krogman A; Tilahun AY; Alexander MP; David CS; Rajagopalan G
J Immunol; 2017 Jun; 198(11):4413-4424. PubMed ID: 28468970
[TBL] [Abstract][Full Text] [Related]
9. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines.
DaSilva L; Welcher BC; Ulrich RG; Aman MJ; David CS; Bavari S
J Infect Dis; 2002 Jun; 185(12):1754-60. PubMed ID: 12085321
[TBL] [Abstract][Full Text] [Related]
10. Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome.
Tilahun AY; Holz M; Wu TT; David CS; Rajagopalan G
PLoS One; 2011 Feb; 6(2):e16764. PubMed ID: 21304813
[TBL] [Abstract][Full Text] [Related]
11. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
D'Orazio JA; Stein-Streilein J
Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
[TBL] [Abstract][Full Text] [Related]
12. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
13. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
Wang S; Li Y; Xiong H; Cao J
Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523
[TBL] [Abstract][Full Text] [Related]
14. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
Karau MJ; Tilahun ME; Krogman A; Osborne BA; Goldsby RA; David CS; Mandrekar JN; Patel R; Rajagopalan G
Virulence; 2017 Oct; 8(7):1148-1159. PubMed ID: 27925510
[TBL] [Abstract][Full Text] [Related]
15. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules.
Soos JM; Johnson HM
Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991
[TBL] [Abstract][Full Text] [Related]
16. Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.
Tilahun ME; Kwan A; Natarajan K; Quinn M; Tilahun AY; Xie C; Margulies DH; Osborne BA; Goldsby RA; Rajagopalan G
PLoS One; 2011; 6(11):e27203. PubMed ID: 22102880
[TBL] [Abstract][Full Text] [Related]
17. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.
Rajagopalan G; Iijima K; Singh M; Kita H; Patel R; David CS
Infect Immun; 2006 Feb; 74(2):1284-96. PubMed ID: 16428778
[TBL] [Abstract][Full Text] [Related]
18. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of allostimulated HLA-DQ and DP-specific T cells by staphylococcal enterotoxin A.
Masewicz S; Ledbetter JA; Martin P; Mickelson E; Hansen JA; Odum N
Hum Immunol; 1993 Mar; 36(3):142-8. PubMed ID: 8320132
[TBL] [Abstract][Full Text] [Related]
20. Localization of binding sites of staphylococcal enterotoxin B (SEB), a superantigen, for HLA-DR by inhibition with synthetic peptides of SEB.
Komisar JL; Small-Harris S; Tseng J
Infect Immun; 1994 Nov; 62(11):4775-80. PubMed ID: 7927754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
